June 2007. Volume 3. Number 2

Adding intravenous corticosteroids to conventional intravenous immune globulin therapy for the treatment of children with Kawasaki disease does not decrease the coronary-artery complications

 
 
 
 
 
 
 
 
 
 
Rating: 0 (0 Votes)
Newsletter Free Subscription
Regularly recieve most recent articles by e-mail
Subscribe
Print
Add to library
Discuss this article

AVC | Critically appraised articles

Newburger JW, Sleeper LA, McCrindle BW, Minichs LL, Gersony W, Vetter VL et al. Randomized trial of pulsed coticosteroid therapy for primary treatment of Kawasaki disease. N Engl J Med. 2007;356:663-75
Reviewers: Aizpurua Galdeano P1, Orejón de Luna G2.
1ABS 7 La Salut Badalona. Badalona. España.
2CS General Ricardos. Madrid. España.
Correspondence: Pilar Aizpurua Galdeano. Email: 19353pag@gmail.com
Reception date: 25/04/2007
Acceptance date: 30/04/2007
Publication date: 01/06/2007

Abstract


How to cite this article

Aizpurua P, Orejón de Luna G. Añadir corticoides intravenosos al tratamiento convencional con inmunoglobulinas y ácido acetil salicílico, no disminuye las complicaciones coronarias en la enfermedad de Kawasaki. Evid Pediatr. 2007;3:33.

AVC | Critically appraised articles

Newburger JW, Sleeper LA, McCrindle BW, Minichs LL, Gersony W, Vetter VL et al. Randomized trial of pulsed coticosteroid therapy for primary treatment of Kawasaki disease. N Engl J Med. 2007;356:663-75
Reviewers: Aizpurua Galdeano P1, Orejón de Luna G2.
1ABS 7 La Salut Badalona. Badalona. España.
2CS General Ricardos. Madrid. España.
Correspondence: Pilar Aizpurua Galdeano. Email: 19353pag@gmail.com
Reception date: 25/04/2007
Acceptance date: 30/04/2007
Publication date: 01/06/2007

How to cite this article

Aizpurua P, Orejón de Luna G. Añadir corticoides intravenosos al tratamiento convencional con inmunoglobulinas y ácido acetil salicílico, no disminuye las complicaciones coronarias en la enfermedad de Kawasaki. Evid Pediatr. 2007;3:33.

References

  1. Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the committee on rheumatic fever, endocarditis and Kawasaki disease, council on cardiovascular disease in the young, American Heart Association. Circulation. 2004;110:2747-71.
  2. Martínez M, del Castillo F, Borque C, García MJ, de José MI, Martínez F et al. Incidencia y características clínicas de la enfermedad de Kawasaki. An Pediatr (Barc). 2003;59:323-7.
  3. Wooditch AC, Aronoff SC. Effect of initial corticosteroid therapy on coronary artery aneurysm formation in Kawasaki disease: a meta-analysis of 862 children. Pediatrics. 2005;116:989-95.
  4. Burns JC. The riddle of Kawasaki disease. N Engl J Med. 2007;356:659-661.
  5. Inoue Y, Okada Y, Shinohara M, Kobayashi T, Kobayashi T, Tomomasa T, et al. A multicente prospective randomized trial of corticosteroids in primary therapy for Kawasaki disease: clinical course and coronary artery outcome. J Pediatr. 2006;149:336-41.
01/06/2007

Linked Comment